Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1984 Jun;60(704):391–393. doi: 10.1136/pgmj.60.704.391

Beta-adrenoceptor and epoprostenol (prostacyclin) responsiveness of lymphocytes in migraine patients.

S A Kilfeather, A Massarella, G Gorgolewska, E Ansell, P Turner
PMCID: PMC2417887  PMID: 6087306

Abstract

Beta-adrenoceptor blocking drugs are of prophylactic value in some patients with migraine. Beta-adrenoceptor responsiveness as measured by lymphocyte cAMP responsiveness to isoprenaline has, therefore, been compared in ten untreated classical migraine patients and ten matched non-migraine control subjects. Lymphocyte responsiveness to epoprostenol (prostacyclin, PGI2) was also compared. No difference in response to either agent was found between the two groups. A generalized abnormality of beta-adrenoceptor function does not appear to be present in classical migraine, but a defect localized to specific vascular regions cannot be excluded.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown B. L., Albano J. D., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971 Feb;121(3):561–562. doi: 10.1042/bj1210561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Lima D. R., Turner P. Beta-blocking drugs increase responsiveness to prostacyclin in hypertensive patients. Lancet. 1982 Aug 21;2(8295):444–444. doi: 10.1016/s0140-6736(82)90475-5. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES